首页 | 本学科首页   官方微博 | 高级检索  
检索        

心脏永久性起搏器的不同起搏部位对植入患者心功能的影响
引用本文:王亚玲,张杨,郭安君,饶明月,张晓丹,孟建康.心脏永久性起搏器的不同起搏部位对植入患者心功能的影响[J].河北医科大学学报,2022,43(1):22-25,30.
作者姓名:王亚玲  张杨  郭安君  饶明月  张晓丹  孟建康
作者单位:河北医科大学第二医院东院心内一科,河北 石家庄 050035
基金项目:河北省医学科学研究课题计划(20190589)
摘    要:目的 探讨心脏永久性起搏器的不同起搏部位对植入患者心功能的影响.方法 我院心血管内科接受心脏永久性起搏器植入术的患者80例,根据患者起搏部位将其分为A组(30例,于右心室心尖部植入心脏永久性起搏器)、B组(50例,于右心室间隔植入心脏永久性起搏器),对两组的临床资料进行回顾性研究分析,比较两组的N末端脑钠肽水平(N-t...

关 键 词:心律失常  心力衰竭  心脏起搏器  人工

Effect of different pacing sites of permanent pacemaker on cardiac function of implanted patients
WANG Ya-ling,ZHANG Yang,GUO An-jun,RAO Ming-yue,ZHANG Xiao-dan,MENG Jian-kang.Effect of different pacing sites of permanent pacemaker on cardiac function of implanted patients[J].Journal of Hebei Medical University,2022,43(1):22-25,30.
Authors:WANG Ya-ling  ZHANG Yang  GUO An-jun  RAO Ming-yue  ZHANG Xiao-dan  MENG Jian-kang
Institution:The First Department of Cardiovascular Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang 050035, China
Abstract:ObjectiveTo explore the effect of different pacing sites of permanent pacemaker on cardiac function of implanted patients.MethodsIn total, 80 patients who received permanent pacemaker implantation in the Department of Cardiology of our hospital were included in the study, and were divided into group A(30 patients with permanent pacemaker implantation at the apex of the right ventricle) and group B(50 patients with permanent pacemaker implantation at the septum of the right ventricle) according to the pacing sites. The clinical data of the two groups were analyzed retrospectively. The levels of N-terminal brain natriuretic peptide(NT-proBNP), cardiac color ultrasound indicators[including left ventricular end-diastolic diameter(LVEDD), left ventricular end-systolic diameter(LVESD) and left ventricular ejection fraction(LVEF)], quality of life score, and incidence of adverse cardiac events were compared between two groups.ResultsThe levels of NT-proBNP after implantation in both groups were significantly lower than those before implantation(P<0.05), while the levels of NT-proBNP after implantation in group B were lower than those in group A, suggesting significant differences(P<0.05). The LVEF, LVEDD and LVESD after implantation were significantly improved in both groups(P<0.05), while the LVEF in group B was higher than that in group A(P<0.05), and the LVEDD and LVESD in group B were lower than that in group A, with significant difference(P<0.05). The quality of life scores(emotional field, physical field, other fields and comprehensive scores) of the two groups were significantly lower after implantation than those before implantation(P<0.05), while the quality of life scores(emotional field, physical field, other fields and comprehensive scores) after implantation in group B were lower than those in group A, with statistical significance(P<0.05). At 6-month follow-up, there were 2 cases of atrial fibrillation, 1 case of heart failure and 2 cases of abnormal heart rate in group A, and 3 cases of atrial fibrillation, 3 cases of heart failure and 1 case of abnormal heart rate in group B. The incidence of adverse cardiac events in group A and group B was 16.67% and 14.00% respectively, and there was no significant difference between two groups(P>0.05).ConclusionImplantation of permanent cardiac pacemakers at different pacing sites has certain influences on patients′ cardiac function. Implantation of permanent cardiac pacemakers into the right side of the interventricular septum can improve patients′ cardiac function better without increasing the risk of adverse cardiac events.
Keywords:asrrhythmias  cardiac  heart failure     pacemaker  artificial   
点击此处可从《河北医科大学学报》浏览原始摘要信息
点击此处可从《河北医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号